ClinicalTrials.gg
CompletedNCT07902895Updated Oct 29, 2026

Intrathoracic Sleeve Migration (Sliding Hiatal Hernia) One Year or More After Laparoscopic Sleeve Gastrectomy

An observational study in Hiatal Hernia, Gastroesophageal Reflux Disease and Obesity, sponsored by Kasr El Aini Hospital. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Kasr El Aini Hospital · Observational

Updated Oct 29, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
61
Ages
18 Years and older
Sex
All
01

Study summary

Sleeve gastrectomy is the most commonly performed metabolic bariatric operation. After the operation, the upper part of the gastric sleeve can slide up through the opening in the diaphragm into the chest. This is called intrathoracic sleeve migration and is a form of sliding hiatal hernia. It may cause new reflux symptoms such as heartburn, regurgitation and vomiting, and may lead to further surgery. How often it happens is uncertain, because studies have used different definitions and tests.

This single-centre observational study included adults who had a laparoscopic sleeve gastrectomy at Cairo University Hospitals between July 2024 and August 2025 and were at least one year after surgery. Each patient had a CT scan of the chest and abdomen with oral contrast to look for migration of the sleeve above the diaphragm, and completed the GERD-Q reflux questionnaire. The study measured how often intrathoracic sleeve migration occurs one year or more after sleeve gastrectomy, whether it is associated with new (de novo) reflux disease, and which patient factors may be associated with it.

Read the detailed description

Background

Laparoscopic sleeve gastrectomy (LSG) is associated with de novo gastro-oesophageal reflux disease (GERD). One proposed mechanism is intrathoracic sleeve migration (ITSM): upward migration of the proximal sleeve, with its staple line, through the oesophageal hiatus after an operation in which the sleeve was entirely intra-abdominal. Reported rates range from about 5% to 45%, largely because of differing diagnostic definitions and imaging methods.

Design and setting

Single-centre observational cohort study in the Department of General Surgery, Cairo University Hospitals (Kasr Al-Ainy), Cairo, Egypt. Patients who underwent primary LSG between July 2024 and August 2025 were identified from the department's records and invited to a single study visit 12 months or more after surgery. Study visits (CT and GERD-Q) took place between April 2026 and September 2026. The protocol was approved by the Research Ethics Committee, Faculty of Medicine, Cairo University (code MS-620-2025) on 11 March 2026, before the first study visit. The study forms the basis of an MSc thesis in General Surgery (candidate: Dr. Dalia Moharam Hussein Mustafa).

Data collection

From the medical records: age, sex, preoperative body mass index (BMI), preoperative GERD status and operative details, to confirm that no hiatal hernia was found at operation and that no hiatal dissection, hiatal repair or sleeve fixation was performed. At the study visit: symptom history (heartburn, regurgitation, vomiting and others) and time of symptom onset after surgery, the GERD-Q questionnaire, and height, weight and BMI.

Imaging

CT of the thorax and abdomen (to the pubis) after oral water-soluble contrast, with 5 mm slices. Images were reconstructed and analysed by a single operator. The level of the oesophageal hiatus was identified along the staple line, and migration of the proximal end of the staple line above the hiatus was measured in millimetres.

Definitions

  • ITSM: proximal end of the sleeve staple line above the level of the oesophageal hiatus on CT.
  • GERD: GERD-Q score of 8 or more.
  • Because patients with GERD or hiatal hernia before surgery were excluded, postoperative GERD is regarded as de novo.

Statistical analysis

SPSS version 26. Normality is assessed with the Shapiro-Wilk test and histograms. Continuous data are summarised as mean and standard deviation or median and interquartile range, and compared between patients with and without ITSM using the Student t-test or the Mann-Whitney U test (paired t-test or Wilcoxon signed-rank test for paired observations). Categorical data are compared with the chi-square or Fisher exact test. A two-sided P value below 0.05 is considered significant.

02

Conditions studied

  • Hiatal Hernia
  • Gastroesophageal Reflux Disease
  • Obesity
  • Postoperative Complications

Keywords

  • Laparoscopic sleeve gastrectomy
  • Intrathoracic sleeve migration
  • Sliding hiatal hernia
  • De novo GERD
  • GERD-Q
  • Computed tomography
  • Metabolic bariatric surgery
03

In context

Hernia, Hiatal

87 studies on the registry are indexed under Hernia, Hiatal; 27 are open to participants now.

This study's enrollment of 61 is below the median of 151 across 29 observational studies indexed under Hernia, Hiatal.

Browse Hernia, Hiatal studies →

Lead sponsor

Kasr El Aini Hospital is the lead sponsor of 287 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with obesity who underwent primary laparoscopic sleeve gastrectomy in the Department of General Surgery, Cairo University Hospitals (Kasr Al-Ainy), between July 2024 and August 2025, identified from the department's records and assessed 12 months or more after surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (18 years or older) with a preoperative above 35 kg/m²
  • Primary laparoscopic sleeve gastrectomy between July 2024 and August 2025
  • 12 months or more after surgery

Exclusion criteria

Exclusion Criteria:

  • Roux-en-Y gastric bypass or one-anastomosis (mini) gastric bypass
  • Revisional bariatric surgery
  • Hiatal hernia or gastro-oesophageal reflux disease diagnosed before surgery
  • Hiatal hernia found at operation
  • Hiatal dissection, hiatal hernia repair or sleeve fixation performed at the index operation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
61 participants (actual)
Patient registry
No

Interventions

  • ProcedureLaparoscopic sleeve gastrectomy

    Primary laparoscopic sleeve gastrectomy performed as part of routine care before enrolment. This is the exposure of interest; it was not assigned by the study.

  • Diagnostic testCT of the thorax and abdomen with oral water-soluble contrast

    Single CT examination at the study visit (5 mm slices) to detect and measure migration of the proximal sleeve staple line above the oesophageal hiatus.

06

What researchers measure

Primary outcomes

  1. Incidence of intrathoracic sleeve migration (ITSM)

    Proportion of patients with ITSM on CT of the thorax and abdomen with oral water-soluble contrast, defined as the proximal end of the gastric sleeve staple line lying above the level of the oesophageal hiatus. The extent of migration above the hiatus is measured in millimetres.

    Time frame: At a single study visit, 12 months or more after laparoscopic sleeve gastrectomy

Secondary outcomes

  1. Association between ITSM and de novo gastro-oesophageal reflux disease (GERD)

    Proportion of patients with GERD, defined as a GERD-Q score of 8 or more (score range 0 to 18; higher scores indicate a higher likelihood of GERD), compared between patients with and without ITSM. Patients with GERD before surgery were excluded, so postoperative GERD is regarded as de novo. Reflux-related symptoms (heartburn, regurgitation, vomiting) and the time of symptom onset after surgery are also compared between the two groups.

    Time frame: At a single study visit, 12 months or more after laparoscopic sleeve gastrectomy

  2. Patient factors associated with ITSM

    Age (years), sex, preoperative body mass index (kg/m²) and BMI reduction (preoperative minus postoperative BMI, kg/m²) compared between patients with and without ITSM.

    Time frame: Preoperative (from medical records) and at a single study visit, 12 months or more after laparoscopic sleeve gastrectomy

07

Study locations

1 site
  • Kasr El Aini Hospital, Cairo University
    Cairo, Egypt
08

References and documents

Publications

  • Saber AA, Shoar S, Khoursheed M. Intra-thoracic Sleeve Migration (ITSM): an Underreported Phenomenon After Laparoscopic Sleeve Gastrectomy. Obes Surg. 2017 Aug;27(8):1917-1923. doi: 10.1007/s11695-017-2589-6. PubMed 28233265 ↗
  • Sarhan MD, Aboueisha HA, Fathy E, AbdelSalam MN, Abdelsalam A. Intra-thoracic Gastric Pouch Migration Following Laparoscopic Sleeve Gastrectomy - Short Term Study. Surg Gastroenterol Oncol. 2024;29(2 Suppl):S24-S29.

Individual participant data

Plan to share: No — Individual participant data will not be shared; aggregate results will be reported in the publication.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2026 to primary completion in Sep 2026, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2026
First posted
Oct 29, 2026
StartActual
Apr 1, 2026
Primary completionActual
Sep 30, 2026
CompletionActual
Sep 30, 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07902895
Responsible party
Ahmed Abdelsalam M (Associate Professor of General Surgery, Kasr El Aini Hospital) — Principal investigator
First posted
Oct 29, 2026
Start date
Apr 1, 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026
Last update
Oct 29, 2026

Study contacts

Ahmed Abdelsalam, MD
principal investigator · Cairo University
Mohamed Hassan Ali Fahmy, MD
study chair · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion